Search

everythinglearnresearchcommunity

for

Search:↓

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

SHA lowers the hairline quickly and patients are usually happy with the results if they are good candidates.

COVID-19 infection and vaccination are linked to hair loss, especially in women and those with nutritional deficiencies.

Ca²⁺-mediated protein citrullination controls cell growth in the CNS and may help treat brain tumors.

The new composite material is safe and has anticoagulant properties.

A man had a rare skin cancer that looked like a bald spot.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Postmenopausal women with excess male hormones may have ovarian tumors, and surgery usually cures them.

LRIG1 is linked to better survival in Merkel cell carcinoma.

Leydig cell tumors can cause high testosterone and symptoms in postmenopausal women, and removing them improves symptoms.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

In post-menopausal women, signs of increased male hormones should be checked for possible ovarian cancer.

An ovarian tumor can cause high male hormones in postmenopausal women.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

A truncated protein linked to breast cancer may change cell adhesion.

Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.

Activated erbB-2 in mice skin causes severe skin and hair abnormalities.

Rare ovarian tumors can cause increased male hormones in postmenopausal women; surgery is an effective treatment.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

Core symptoms in breast cancer chemotherapy remain stable, aiding targeted interventions.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

A woman's excess male hormone symptoms were caused by a rare benign tumor in her ovary.

Ovarian hyperthecosis can cause polycythemia, and surgery can normalize symptoms.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.